Lung transplantation for cystic fibrosis: Effective and durable therapy in a high-risk group

Annals of Thoracic Surgery

Volumn 66, Issue 2, 1998, Pages 337-345

  Egan, Thomas M ^a   Detterbeck, Frank C ^a   Mill, Michael R ^a   Gott, Kristi K ^a   Rea, Jean B ^a   McSweeney, Judy ^a   Aris, Robert M ^a   Paradowski, Linda J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGE; ANTIBIOTIC SENSITIVITY; ARTICLE; BODY WEIGHT; BRONCHIOLITIS; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOMEGALOVIRUS; FEMALE; GRAFT REJECTION; HIGH RISK POPULATION; HUMAN; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031663322     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00496-2     Document Type: Article

References (27)

1. Patient Registry 1996 Annual Data Report. 1997;Cystic Fibrosis Foundation, Bethesda, MD.
2. Egan T.M., Detterbeck F.C., Mill M.R., et al. Improved results of lung transplantation for patients with cystic fibrosis. J Thorac Cardiovasc Surg. 109:1995;224-235.
3. Pasque MK, Cooper JD, Kaiser LR, Haydock DA, Triantafillou A, Trulock EP. Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg 1990;49:785-11.
4. Starnes V.A., Barr M.L., Cohen R.G. Lobar transplantation indications, technique, and outcome . J Thorac Cardiovasc Surg. 108:1994;403-411.
5. Kerem E., Reisman J., Corey M., Canny G.J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 326:1992;1187-1191.
6. Aris R.M., Neuringer I.P., Weiner M.A., Egan T.M., Ontjes D. Severe osteoporosis before and after lung transplantation. Chest. 109:1996;1176-1183.
7. Aris R.M., Gilligan P.H., Neuringer I.P., Gott K.K., Rea J., Yankaskas J.R. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med. 155:1997;1699-1704.
8. Egan T.M., Detterbeck F.C. Technique and results of double lung transplantation. Chest Surg Clin N Am. 3:1993;89-111.
9. Noirclerc M.J., Metras D., Vaillant A., et al. Bilateral bronchial anastomosis in double lung and heart-lung transplantations. Eur J Cardiothorac Surg. 4:1990;314-317.
10. Egan T.M., Thompson J.T., Detterbeck F.C., et al. Effect of size (mis)matching in clinical double-lung transplantation. Transplantation. 59:1995;707-713.
11. Tan K.K.C., Trull A.K., Uttridge J.A., Wallwork J. Relative bioavailability of cyclosporin from conventional and microemulsion formulations in heart-lung transplant candidates with cystic fibrosis. Eur J Clin Pharmacol. 48:1995;285-289.
12. Dupuis RE, Gott KK, Smith AW, Paradowski LJ, Egan TM, Aris RM. Conversion of Sandimmune to Neoral in lung transplant recipients with cystic fibrosis. Pediatr Pulmonol (Suppl) (in press).
13. Cooper J.D., Billingham M., Egan T., et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts [Consensus Document]. J Heart Lung Transplant. 12:1993;713-716.
14. Aris R.M., Maia D.M., Neuringer I.P., et al. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient. Am J Respir Crit Care Med. 154:1996;1712-1717.
15. Knowles M., Gatzy J., Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med. 305:1981;1489-1495.
16. Riordan J.R., Rommens J.M., Kerem B.-S., et al. Identification of the cystic fibrosis gene cloning and characterization of complementary DNA . Science. 245:1989;1066-1073.
17. Snouwaert J.N., Brigman K.K., Latour A.M., et al. An animal model for cystic fibrosis made by gene targeting. Science. 257:1992;1083-1088.
18. Yacoub M.H., Banner N.R., Khaghani A., et al. Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant. 9:1990;459-467.
19. Frist W.H., Fox M.D., Campbell P.W., Fiel S.B., Loyd J.E., Merrill W.H. Cystic fibrosis treated with heart-lung transplantation North American results . Transplant Proc. 23:1991;1205-1206.
20. De Leval M.R., Smyth R., Whitehead B., et al. Heart and lung transplantation for terminal cystic fibrosis. a 4-1/2-year experience. J Thorac Cardiovasc Surg. 101:1991;633-643.
21. Ramirez J.C., Patterson G.A., Winton T.L., et al. Bilateral lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg. 103:1992;287-294.
22. Shennib H., Noirclerc M., Ernst P., et al. Double-lung transplantation for cystic fibrosis. Ann Thorac Surg. 54:1992;27-32.
23. Hosenpud J.D., Novick R.J., Bennett L.E., Keck B.M., Fiol B., Daily O.P. The Registry of the International Society for Heart and Lung Transplantation thirteenth official report - 1996 . J Heart Lung Transplant. 15:1996;655-674.
24. Lin S.S., Platt J.L. Immunologic barriers to xenotransplantation. J Heart Lung Transplant. 15:1996;547-555.
25. Egan T.M., Lambert C.J. Jr, Reddick R.L., Ulicny K.S. Jr, Keagy B.A., Wilcox B.R. A strategy to increase the donor pool the use of cadaver lungs for transplantation . Ann Thorac Surg. 52:1991;1113-1121.
26. Ulicny K.S. Jr, Egan T.M., Lambert C.J. Jr, Reddick R.L., Wilcox B.R. Cadaver lung donors effect of preharvest ventilation on graft function . Ann Thorac Surg. 55:1993;1185-1191.
27. Roberts C.S., D'Armini A.M., Egan T.M. Canine double-lung transplantation with cadaver donors. J Thorac Cardiovasc Surg. 112:1996;577-583.